Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary Stents

Abstract

Treatment of de novo coronary stenosis with sirolimus-eluting stents was associated with a sustained clinical benefit and very low rates of TLR and of other MACE up to 3 years after device implantation.